Cystic fibrosis (CF) is the most common inherited rare disease in North America and Europe, with more than 27,000 cases in the US and more than 35,000 cases in the European Union (EU) (Cystic Fibrosis Foundation Patient Registry, 2011; Farrell, 2008). CF causes abnormally thick, sticky mucus to accumulate in the respiratory, digestive, and reproductive systems. It is one of the most common chronic lung diseases and is widespread throughout the world. The specific defective gene that cases CF is the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Key differences in the CF epidemiology between countries are influenced by genotype mutations, national screenings, and surveillance systems through national registries. GlobalData forecasts that the US and UK will have the most prevalent cases of CF in 2022. In 2022, the combined prevalent CF cases in the 5EU countries (France, Germany, Italy, Spain, and the UK) will be slightly larger than the number of prevalent CF case
Original Post EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2022
Browse All Reports: Latest Market Research Reports
Browse All Reports: Countrywide Market Research Reports
Browse All Reports: Transparency Market Research Reports
Browse All Reports: Technavio Market Research Reports
Browse All Reports: Winter Green Market Research Reports
Browse All Reports: QY Market Research Reports
Browse All Reports: GBI Market Research Reports
Browse All Reports: Select Biosciences Market Research Reports
Contact: sales@researchmoz.usfor further information.
No comments:
Post a Comment